ArticleJournal of proteome research2025
Activating Cancer Hallmarks through Changes in mRNA/Protein Regulation.
Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pan-Cancer Quantification of Driver Alteration Transmission Across Molecular Layers Reveals Limited Propagation to Protein Abundance.International journal of cancer · 2026Article
- The AGO2 adaptor LIMD1 expands the functional and evolutionary reach of microRNA targeting.Science advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
As a diverse family of diseases, cancer is unified by a set of common dysfunctions, such as limitless growth potential and an insensitivity to antigrowth signals. These shared overarching biological processes have been termed the hallmarks of cancer. To better understand the root cause of cellular dysregulation, intense molecular characterization of tumors has utilized DNA, RNA, and protein measurement techniques to produce proteogenomic data. In large cancer cohort studies, genomic and proteogenomic data have frequently identified many cancer hallmarks including cell cycle and cell signaling. However, altered metabolism, a known cancer hallmark, is not as clearly identified in mutation screens or differential expression analyses. Here, we introduce a new computational method to identify changes in cellular regulation by focusing on the mRNA/protein relationship. We create a metric, Δ_corr, to capture when the mRNA/protein correlation changes significantly between tumor and normal tissues and show that it is distinct from differential expression and also not associated with DNA mutation profiles. Our method clearly highlights altered metabolic pathways across multiple tumor types. Δ_corr gives researchers a new perspective on the dysfunction of tumor cells and introduces a novel method for proteogenomic data integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.